Medtronic MiniMed series of insulin pump systems makes it easier for patients to stay in range, making them 4 times more likely to reach their HbA1c target and reduce low glucose episodes by up to 84 percent. The MiniMed range can be integrated with the Medtronic Guardian CGM transmitter and the Ascensia Contour Next glucometer for total diabetes control.
Benefit of MiniMed to clinical trials
- SmartGuard technology which takes action if a patient’s glucose values go below a pre-set level
- User-friendly and waterproof protection
- Bolus wizard calculator to avoid insulin stacking
- Integration of CGM, glucometer and insulin pump therapy through one device